Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study identifies a potential new treatment approach for acute myeloid leukemia

Study identifies a potential new treatment approach for acute myeloid leukemia

Research shows the benefits of screening AML patients in remission for residual disease before bone marrow transplant

Research shows the benefits of screening AML patients in remission for residual disease before bone marrow transplant

Biden administration urged to take more aggressive steps to relieve medical debt

Biden administration urged to take more aggressive steps to relieve medical debt

New research pinpoints key culprit behind brain cancer metastasis in children

New research pinpoints key culprit behind brain cancer metastasis in children

Even small bouts of exercise protective against heart disease, cancer

Even small bouts of exercise protective against heart disease, cancer

Research identifies a possible treatment strategy for rare bone marrow failure syndrome

Research identifies a possible treatment strategy for rare bone marrow failure syndrome

Reprogrammed tumor cells could teach the body's immune system to fight cancer

Reprogrammed tumor cells could teach the body's immune system to fight cancer

Using vitamin B5 supplementation to boost red blood cell production in people with myelodysplastic syndromes

Using vitamin B5 supplementation to boost red blood cell production in people with myelodysplastic syndromes

Just 75 weekly minutes of physical activity can reduce the risks of early death and disease

Just 75 weekly minutes of physical activity can reduce the risks of early death and disease

University of Vermont Cancer Center to offer a novel, highly effective form of cancer treatment

University of Vermont Cancer Center to offer a novel, highly effective form of cancer treatment

Study identifies a potential new targeted drug for treating acute myeloid leukemia

Study identifies a potential new targeted drug for treating acute myeloid leukemia

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

Fetal cell program appears to protect against acute myeloid leukemia

Fetal cell program appears to protect against acute myeloid leukemia

HKU research advances understanding of the fundamental biological processes of gene regulation

HKU research advances understanding of the fundamental biological processes of gene regulation

395 genes found to be differently expressed in people with type 2 diabetes

395 genes found to be differently expressed in people with type 2 diabetes

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform

Protein degradation approach can be used to hit an ‘undruggable’ target against cancer

Protein degradation approach can be used to hit an ‘undruggable’ target against cancer

Your money or your life: Patient on $50,000-a-week cancer drug fears leaving behind huge medical debt

Your money or your life: Patient on $50,000-a-week cancer drug fears leaving behind huge medical debt

Personalizing CAR-T cell stimulation during manufacturing can enhance its functionality

Personalizing CAR-T cell stimulation during manufacturing can enhance its functionality

The possible role of the endometrial microbiome as an immune modulator in the phase of implantation and during pregnancy

The possible role of the endometrial microbiome as an immune modulator in the phase of implantation and during pregnancy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.